Mechanistic studies demonstrated that Sparcl1 is a regulator of NASH progression by promoting the expression of C-C motif chemokine ligand 2 through Toll-like receptor 4/NF-κB signaling pathway (11). The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatohepatitis.